July 09, 2018

Endocyte and ITM announce Long-Term Supply Agreement for no-carrier-added Lutetium-177

Strategic Partnership supports Commercialization beyond ongoing Phase 3 VISION Trial of 177Lu-PSMA-617

Full releases >>

July 06, 2018

Bruce Power joins forces with ITM to supply Lutetium-177 for cancer therapy

Bruce Power to secure global supply of no-carrier-added Lutetium-177 through 2064. ITM to achieve new scalability of n.c.a Lutetium-177 (EndolucinBeta®)

Full releases >>

June 19, 2018

FDA Acceptance of IND to advance Phase III Clinical Trial COMPETE with Solucin® for Treatment of GEP-NET in the U.S.

Recruitment in the U.S. for the COMPETE trial to begin shortly. Solucin® studied as a first-line therapy. Exclusively-produced nephroprotective amino acid solution administered.

Full releases >>

June 05, 2018

ITM announces appointment of Philip E. Harris as new Chief Medical Officer

ITM Isotopen Technologien München AG (ITM), a specialized radiopharmaceutical company, today announced the appointment of Philip E. Harris, BSc MB BCh PhD FRCP FRCB, to the position of Chief Medical Officer (CMO), starting on...

Full releases >>

May 25, 2018

Marketing Authorization for TOCscan® (68Ga-Edotreotide) in Germany, Austria and France

ITM receives marketing authorization for a ready-to-use radiopharmaceutical in 3 European countries. TOCscan® will be the companion diagnostic in ITM´s theranostic approach for the treatment of Neuroendocrine Tumors.

Full releases >>

May 17, 2018

ITM Isotopen Technologien München AG chosen as a 2018 Red Herring Top 100 Europe Winner

Acknowledgement of ITM’s success in bringing a new promising therapy in Precision Oncology to market and to the patients

Full releases >>

May 02, 2018

ITM Isotopen Technologien München AG unterzeichnet Charta der Vielfalt

Mit der Unterstützung der Initiative „Diversity als Chance – die Charta der Vielfalt der Unternehmen in Deutschland“ setzt ITM Isotopen Technologien München AG ein wichtiges Zeichen für die Anerkennung von Vielfalt in der...

Full releases >>